Tscan Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $3,076 | $2,171 | $665 | $1,049 |
Gross Profit | 3,076 | 2,171 | -45 | 1,049 |
EBITDA | -35,565 | -32,770 | -34,314 | -27,902 |
EBIT | -36,263 | -33,448 | -35,025 | -28,929 |
Net Income | -36,952 | -34,127 | -35,809 | -29,887 |
Net Change In Cash | 3,076 | 2,171 | 665 | 1,049 |
Free Cash Flow | -34,546 | -39,118 | -28,300 | -29,288 |
Cash | 169,394 | 154,108 | 178,689 | 133,118 |
Basic Shares | 129,730 | 129,678 | 120,789 | 118,700 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $2,816 | $21,049 | $13,535 | $10,141 |
Gross Profit | 2,816 | -67,104 | 8,398 | 6,813 |
EBITDA | -119,738 | -80,098 | -59,908 | -45,297 |
EBIT | -123,846 | -85,459 | -65,045 | -48,625 |
Net Income | -127,499 | -89,218 | -65,806 | -48,625 |
Net Change In Cash | 2,816 | 21,049 | 13,535 | 10,141 |
Cost of Revenue | -41,372 | 131,050 | ||
Free Cash Flow | -114,647 | -64,504 | -70,728 | -58,618 |
Cash | 178,689 | 133,359 | 120,027 | 161,405 |
Basic Shares | 111,990 | 65,599 | 24,048 | 23,907 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.28 |
2025-03-31 | -$0.60 |
2024-12-31 | -$0.30 |
